| 000 | 00000nam##2200000za#4500 |
| 001 | 9.559317 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624172823 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150406|2005||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a0-662-39768-1 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH113-12/2005-2E-PDF |
|---|
| 110 | 1 |aCanada. |bPest Management Regulatory Agency. |
|---|
| 245 | 10|a10,10'-oxybis(phenoxarsine) |h[electronic resource] |
|---|
| 260 | |bHealth Canada. |c2005. |
|---|
| 300 | |a4p. |
|---|
| 490 | 1 |aRe-evaluation decision document |vRRD 2005-02 |
|---|
| 520 | 3 |aRe-evaluation Decision Documents are used to announce the Agency's final decision concerning an active ingredient, which has been under re-evaluation in Canada. Re-evaluation Decision Documents may follow a Re-evaluation Note (REV) or a Proposed Acceptability for Continuing Registration (PACR). The document explains how the final decision was made. |
|---|
| 590 | |a05-13|b2005-04-01 |
|---|
| 775 | 08|t10,10'-oxybis(phénoxarsine) |w(CaOODSP)9.592094 |
|---|
| 776 | 0#|t10,10'-oxybis(phenoxarsine) |w(CaOODSP)9.617263 |
|---|
| 830 | #0|aRe-evaluation decision document ;|vRRD 2005-02|w(CaOODSP)9.504451 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s137 KB|uhttps://publications.gc.ca/collections/Collection/H113-12-2005-2E.pdf|yRRD 2005-02 |
|---|